Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pseudogenes are nonfunctional DNA sequences derived from protein-coding genes that have lost their protein-coding potential due to accumulating mutations. While some pseudogenes can play regulatory roles at the RNA level, the vast majority, including family with sequence similarity 154, member B pseudogene (ENSG00000259609), are considered biologically inactive and are not therapeutic targets. Their presence may be relevant in genomic studies, but they lack druggable function[3]. ENSG00000259609, "family with sequence similarity 154, member B pseudogene," is a pseudogene and is not a valid therapeutic target or functional molecule for drug development or biomarker purposes[3]. If you intended to retrieve information on a protein-coding gene or a true therapeutic target, please clarify the designation.
Null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 154, member B pseudogene (Null).